Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Structure Therapeutics Inc. American Depositary Shares
GPCRCurrent price
34.17 USD
-3.58 USD (-9.48%)
Last closed
37.69 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 174 610 944 USD
Yield for 12 month
-28.74 %
1Y
3Y
5Y
10Y
15Y
GPCR
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company's lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. It is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist for apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF); and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF and PPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. Address: 601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
87.9 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-949 174 USD
Last Year
-623 258 USD
Current Quarter
-231 736 USD
Last Quarter
-658 927 USD
Key Figures GPCR
1 year
3 years
5 years
10 years
EBITDA
-121 844 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.01 %
PEG Ratio
–
Return On Equity TTM
-17.69 %
Wall Street Target Price
87.9 USD
Revenue TTM
–
Book Value
16.1 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.19 USD
Diluted Eps TTM
-2.19 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GPCR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GPCR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GPCR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-13.463
Price Book MRQ
2.3617
Financials GPCR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GPCR
For 52 weeks
26.61 USD
66.38 USD
50 Day MA
39.5 USD
Shares Short Prior Month
10 548 981
200 Day MA
40.22 USD
Short Ratio
14.27
Shares Short
10 804 208
Short Percent
22.42 %
BeatStart